Jupiter Life Line Hospitals Ltd IPO Timeline

Jupiter Life Line Hospitals Ltd IPO opens on 06-Sep-2023, and closes on 08-Sep-2023. The Jupiter Life Line Hospitals Ltd IPO bid date is from 06-Sep-2023 to 08-Sep-2023. The Cut-off time for UPI Mandate confirmation is 12 P.M. on the next day of issue closing day.

Event Date
Jupiter Life Line Hospitals Ltd IPO Opening Date 06-Sep-2023
Jupiter Life Line Hospitals Ltd IPO Closing Date 08-Sep-2023
Basis of Allotment 13-Sep-2023
Initiation of Refunds 14-Sep-2023
Credit of Shares to Demat 15-Sep-2023
Jupiter Life Line Hospitals Ltd IPO Listing Date 18-Sep-2023

Jupiter Life Line Hospitals Ltd IPO Lot Size

Jupiter Life Line Hospitals Ltd IPO lot size is 20 shares. A retail-individual investor can apply for up to 13 lots (260 shares or 191100).

Application Lots Shares Amount
Minimum 1 20 ₹14700
Maximum 13 260 ₹191100

Jupiter Life Line Hospitals Ltd IPO Details

Jupiter Life Line Hospitals Ltd IPO Date 06-Sep-2023 to 08-Sep-2023
Jupiter Life Line Hospitals Ltd IPO Face Value Shares of ₹10 per share
Jupiter Life Line Hospitals Ltd IPO Price ₹695 to ₹735 per share
Jupiter Life Line Hospitals Ltd IPO Lot Size 20
Issue Size Shares of ₹10 (aggregating up to ₹869.08 Cr)
Fresh Issue Shares of ₹10 (aggregating up to ₹542 Cr)
Offer for Sale Shares of ₹10 (aggregating up to ₹327.08 Cr)
Issue Type Book Built Portion
Listing At BSE, NSE
QIB Shares Offered Not more than 2372880
Retail Shares Offered Not less than 4287002
NII (HNI) Shares Offered Not less than 1837287
Company Promoters Ajay Thakker, Ankit Thakker, Western Mediacal Solutions LLP.

Objects of the Issue

The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:

  • 1 Repaymnet/pre-payment in full or part, of borrowings availed from banks by the company and material subsidiary
  • 2 General corporate purposes

Company Financials

Jupiter Life Line Hospitals Ltd Financial Information (Restated)

Period Ended Total Assets Total Revenue Profit After Tax
03-2023 885.34 800.62 107.21
03-2022 754.75 661.03 84.67
03-2021 614.56 465.12 16.59
Amount in ₹ Crore
  • Key multi-specialty tertiary and quaternary healthcare provider with a track record of over 15 years, strong brand recognition and clinical expertise.
  • 'All-hub-no-spoke' model with focus on quality patient care supported by modern infrastructure and technological capabilities.
  • Ability to attract and retain skilled and experienced healthcare professionals.
  • Track-record of operational and financial performance with a diversified revenue mix.
  • Experienced and qualified professional management team with a focus on environmental, social and governance initiatives.
  • The Hospital is highly dependent on its healthcare professionals including doctors and nurses, and any future inability to attract/ retain such professionals will adversely affect the Hospital business, financial condition and results of operations.
  • Its revenues are significantly dependent on its hospital in Thane. Further, all the hospitals are located in the western regions of India. Any impact on the revenues of its Thane hospital or any change in the economic or political circumstances of western India or particularly in or around Thane, could materially affect its business, financial condition and results of operations.
  • The Hospital industry is highly regulated and requires it to obtain, renew and maintain statutory and regulatory permits, accreditations, licenses and comply with applicable safety, health, environmental, labour and other governmental regulations. Any regulatory changes or violations of such rules and regulations may adversely affect its business, financial condition and results of operations.
  • Any inability to pass on its costs including high medical equipment cost, manpower cost and infrastructure maintenance and repair cost, to its patients, may have an adverse impact on its business, financial condition and results of operations.
  • Its ability to provide affordable healthcare depends on the maintenance of a high volume of patients, occupancy rates, managing project costs and effective capital management. Any increase in such costs could adversely affect its business, financial condition and results of operations.
  • The Hospital may experience delays in construction or commencement of operations of its proposed hospitals or the Hospital may be unsuccessful in implementing its growth plans of expansion in western India in a timely manner or at all, which may have an adverse effect on its business, financial condition and results of operations.
  • The Hospital relies on certain third parties, including suppliers, and also enter into contracts with third-party payers such as insurance Hospital, third party administrators, corporations and government departments. Termination, non- renewal or any breach of the conditions of such contracts could have a material adverse impact on its business, financial condition and results of operations.
  • Pricing regulations and related government reforms in the healthcare industry and associated uncertainty may adversely affect its business, financial condition and results of operations.
  • An inability to keep pace with technological changes, new equipment, replacement of obsolete equipment and service introductions, changes in patients' needs and evolving industry standards as well as failure or malfunction of its medical or other equipment could adversely affect its business, financial condition and results of operations.
  • Any failure to maintain and enhance its brand and reputation, and any negative publicity and allegations in the media against the hospital, may adversely affect the level of trust in its services and market recognition, which could further result in an adverse impact on its business, financial condition and results of operations.
  • If the Hospital does not receive payments on time from the payers, its business, financial condition and results of operations may be adversely affected.
  • The Hospital faces competition from other healthcare service providers and an inability to compete effectively could adversely affect its business, financial condition and results of operations.
  • The Hospital is subject to various operational, reputational, medical and legal claims, regulatory actions or other liabilities arising from the provision of healthcare services and may be subject to liabilities arising from claims of malpractice and medical negligence which could materially and adversely affect its reputation and prospects.
  • The Hospital's insurance coverage may not be sufficient to cover all possible economic losses, which could have an adverse effect on its business, financial condition and results of operations.
  • Its indebtedness and the conditions and restrictions imposed by its financing agreements and any non-compliance may lead to, amongst others, suspension of further drawdowns, which may adversely affect its business, financial condition and results of operations.
  • An inability to protect its intellectual property rights, or any exposure to misappropriation and infringement claims by third parties, could have an adverse effect on its business, reputation, financial condition and results of operations.
  • The Hospital may be subject to labour unrest, slowdowns and work stoppages, which could affect its reputation, business, financial condition and results of operations.
  • The Hospital's patients may contract serious communicable infections or diseases at its hospitals due to the risks typically associated with the operation of medical care facilities.
  • The Hospital uses highly flammable and explosive materials in its activities which expose it to the risk of loss due to fire. Any fire accidents may have a material adverse effect on the Hospital business, financial condition and results of operations.
  • The Hospital could be exposed to risks relating to the handling of personal information, including medical data.
  • The Hospital incurred losses in Fiscal 2021 and may incur losses in the future. Its Subsidiaries have also incurred losses and have had negative cash flows from operating activities in the past and may continue to incur losses and have negative cash flows in the future.
  • An inability to establish and maintain effective internal controls could lead to an adverse effect on its business and reputation.
  • The Hospital is dependent upon the experience and skill of its management team, a number of key managerial personnel and senior management personnel. If the Hospital is unable to attract or retain such qualified personnel, this could adversely affect its business, financial condition and results of operations.
  • The COVID-19 pandemic had affected its business operations which had an adverse effect on its business, financial condition and results of operations.
  • There are outstanding litigation against the company, Promoter(s), Directors and Subsidiaries. An adverse outcome in any of these proceedings may affect its reputation and standing and impact the Hospital future business and could have a material adverse effect on its business, financial condition, results of operations and cash flows.
  • The Hospital has certain contingent liabilities that has not been provided for in its financial statements, which if they materialize, may adversely affect the financial condition.
  • Its ability to pay dividends in the future will depend on its earnings, financial condition, working capital requirements, capital expenditures and restrictive covenants of its financing arrangements.
  • Lack of health insurance in India may adversely affect its business, financial condition and results of operations.
  • Certain sections of this Draft Red Herring Prospectus disclose information from the CRISIL Report which has been prepared exclusively for the Offer and commissioned and paid for by it exclusively in connection with the Offer, and any reliance on such information for making an investment decision in the Offer is subject to inherent risks.
  • The Hospital has in this Draft Red Herring Prospectus included certain non-GAAP financial measures and certain other industry measures related to its operations and financial performance that may vary from any standard methodology that is applicable across the industry it operates.
  • While the Company will receive proceeds from the Fresh Issue, it will not receive any proceeds from the Offer for Sale.
  • Certain Equity Share allotment related forms filed by it between 2004 and 2009 with the RoC and certain corresponding secretarial records thereto had some discrepancies and/or typographical errors.
  • The Hospital has not disclosed the reason for not having spent the prescribed amount towards its corporate social responsibility requirements in the report issued by its Board for Fiscal 2020.
  • Acquisitions, strategic investments, partnerships or alliances may be difficult to integrate, and may adversely affect its business, financial condition and results of operations.
  • Its Promoters and Promoter Group will continue to retain significant shareholding in the Company after the Offer, which will allow them to exercise significant influence over it.
  • Its Promoter, namely Dr. Ankit Thakker has pledged his Equity Shares with a lender. Any exercise of such pledge by the lender could dilute the shareholding of the Promoters and Promoter Group, which may adversely affect its reputation and share price.
  • Its business depends significantly on the continued effectiveness of its information technology infrastructure, and failure of such technology could adversely impact its business, financial condition and results of operations.
  • The Hospital has not entered into any definitive arrangements to utilize certain portions of the Net Proceeds of the Offer. Its funding requirements and deployment of the Net Proceeds of the Offer are based on management estimates and have not been independently appraised.
  • Any variation in the utilisation of the Net Proceeds would be subject to certain compliance requirements, including prior shareholders' approval.
  • Its Promoters and certain of the Directors and Senior Management Personnel hold Equity Shares in the Company and have interests in the Company and its Subsidiaries other than their normal remuneration or benefits and reimbursement of expenses.
  • The Hospital has in the past entered into related party transactions and will continue to do so in the future and it cannot assure you that the Hospital could not has achieved more favorable terms if such transactions had not been entered into with related parties.
  • The Hospital has issued Equity Shares during the preceding twelve months at a price which may be below the Offer Price.
  • Its Equity Shares have never been publicly traded, and, after the Offer, its Equity Shares may experience price and volume fluctuations, and an active trading market for its Equity Shares may not develop. The determination of the Price Band is based on various factors and assumptions, and the Offer Price of its Equity Shares may not be indicative of the market price of its Equity Shares after the Offer.
  • Some of its Promoters and Directors may have interest in entities or one or more ventures, which are in the similar line of business as the Company and this may result in conflict of interest with it.
  • Strategically expand its footprint in western markets.
  • Continue to recruit and retain skilled healthcare professionals.
  • Pursue strategic inorganic growth opportunities in its focus micro-markets.
  • Continue to improve quality of care and invest and employ latest technology.

Jupiter Life Line Hospitals Ltd IPO Promoter Holding

Pre Issue Share Holding 40.69%
Post Issue Share Holding 36.11%

Jupiter Life Line Hospitals Ltd IPO Subscription Status (Bidding Detail)

The Jupiter Life Line Hospitals Ltd IPO is subscribed 63.72 times on Sep 08, 2023 05:00:00 PM. The public issue subscribed 7.73 times in the retail category, 187.32 times in the QIB category, and 34.75 times in the NII category. Check Day by Day Subscription Details (Live Status)

Category QIB NII Retail Employee Total
Subscription (times) 187.32 34.75 7.73 - 63.72

Jupiter Life Line Hospitals Ltd IPO Prospectus

Jupiter Life Line Hospitals Ltd IPO Listing Date

Listing Date 18 Sep 23
BSE Script 543980
NSE Symbol JLHL
Listing In BSE, NSE
ISIN INE682M01012
IPO Price ₹735
Face Value ₹10

Jupiter Life Line Hospitals Ltd IPO Registrar

KFin Techologies Ltd

Phone: +91 40 6716 2222
Email: jupiterlife.ipo@kfintech.com
Website: www.kfintech.com

Jupiter Life Line Hospitals Ltd IPO Lead Manager(s)

  1. ICICI Securities Ltd
  2. Nuvama Wealth Management Ltd
  3. JM Financial Ltd

FAQs on Jupiter Life Line Hospitals Ltd IPO

Jupiter Life Line Hospitals Ltd IPO, which opens for subscription from 06-Sep-2023 to 08-Sep-2023 has an issue size of ₹869.08 crore. The issue type is book building issue.

In case of pre-apply, your IPO order will be placed on the Exchange as soon as the official bidding for Jupiter Life Line Hospitals Ltd IPO begins. You will receive a UPI request within 24 hours after the bidding period opens.

Jupiter Life Line Hospitals Ltd IPO Opens for subscription from 06-Sep-2023 to 08-Sep-2023.

The lot size of Jupiter Life Line Hospitals Ltd is 20 shares. Retail investors can subscribe to minimum 1 lot and maximum 13 lots. The minimum and maximum application value is ₹14700 and ₹191100 respectively.

Allotment date for Jupiter Life Line Hospitals Ltd is 13-Sep-2023 and refund of application amount (in case allotment is not received) will begin from 14-Sep-2023. If your allotment goes through, then shares will be credited in your Demat account by 15-Sep-2023.

The registrar for Jupiter Life Line Hospitals Ltd IPO is KFin Techologies Ltd . You can check your IPO allotment status on the registrar's website.

The shares of Jupiter Life Line Hospitals Ltd are proposed to be listed on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

Power your investments with our smart trading platforms

mobilefooterimg
  • app_download_icon_img
    5 million+
    App downloads
  • 1_Click_icon_img
    1-Click
    Order Placement
  • higherreturns_icon_img
    1,316 Crore+
    Average Daily Turnover